IL10 and COVID-19: This is consistent with the clinical observations which showed elevated circulating levels of IL-10 in patients with CRS associated with COVID-19, TGN1412, and CAT-T cell therapy (Suntharalingam et al., 2006; Morris et al., 2021; Yang et al., 2021).